O'SULLIVAN COLIN P. 4
Research Summary
AI-generated summary
VSee Health Director Colin O'Sullivan Receives 40,107-Share Award
What Happened
Colin O'Sullivan, a director of VSee Health, acquired 40,107 shares on March 4, 2026. The shares were issued at $0.37 each for a total reported value of $15,000 as an award/grant (transaction code A) in connection with his director services.
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (appears timely).
- Shares: 40,107 common shares issued at $0.37 per share; total value reported $15,000.
- Transaction type/code: Award/Grant (A) — shares issued, not an open-market purchase or sale.
- Shares owned after transaction: Not specified in the filing.
- Footnote: Shares were issued under the issuer's 2024 Incentive Plan per the non-employee director compensation policy for services during the quarter ended Dec 31, 2025; the number issued was based on the closing price on Dec 31, 2025.
Context
This was a routine director compensation issuance (an award) rather than a market purchase or sale. Such grants are common as part of non-employee director pay and should not be interpreted alone as a buy/sell signal about company prospects.